Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Brian Jankowitz

Neurological Surgery Philadelphia, PA Medical Doctor

NPI 1740360247 CMS profile 33207

3400 Civic Center Boulevard, 15Th Floor South Pavilion, Philadelphia, PA 19104

Open in the dashboard

General payments

$823,277

1,111 records reported · program years 2019–2025

Research payments

$18,340

Paid to them · 8 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$155,081 paid to institutions, not to them · program years 2019–2023

Through program year 2025, Brian Jankowitz of Philadelphia, PA is reported in the CMS Open Payments database as having received $823,277 across 1,111 general payments and $18,340 in research payments paid to them. Separately, studies naming them as principal investigator received $155,081 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 98th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

10 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $123,605 221
2024 General $94,077 154
2023 General $133,916 146
2023 Research $6,640 2
2022 General $142,993 163
2021 General $37,570 110
2020 General $187,542 147
2020 Research $450 1
2019 General $103,574 170
2019 Research $11,250 5

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Brian Jankowitz
  • Neurological Surgery median
  • Middle half of Neurological Surgery
  • National median

In program year 2025, general payments to Brian Jankowitz were reported at $123,605. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.

Show as a table
Year Brian Jankowitz Neurological Surgery median Middle half National median
2019 $103,574 $582 $138–$3,006 $163
2020 $187,542 $294 $76–$2,174 $114
2021 $37,570 $387 $105–$2,432 $132
2022 $142,993 $542 $139–$2,989 $149
2023 $133,916 $534 $145–$2,697 $160
2024 $94,077 $574 $155–$3,046 $164
2025 $123,605 $596 $159–$3,102 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $351,593 291 payments
  2. Medtronic, Inc. $88,170 125 payments
  3. Medical Device Business Services, Inc. $67,426 84 payments
  4. Balt USA, LLC $66,460 87 payments
  5. Medtronic USA, Inc. $53,876 56 payments
  6. Portola Pharmaceuticals, Inc. $27,725 44 payments
  7. Rapid Medical LTD $25,970 41 payments
  8. Zimmer Biomet Holdings, Inc. $19,000 35 payments
  9. Imperative Care, INc $15,114 39 payments
  10. MIVI Neuroscience, Inc. $14,772 4 payments
  11. Other $93,172 305 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $530,129 175 payments
  2. Travel and Lodging $148,744 272 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $62,700 18 payments
  4. Food and Beverage $49,944 618 payments
  5. Honoraria $30,510 27 payments
  6. Education $1,250 1 payment
Products named General payments · program years 2019–2025
  1. ATLAS $126,627 52 payments
  2. SURPASS EVOLVE $72,907 37 payments
  3. TARGET $40,402 20 payments
  4. CATALYST $38,346 3 payments
  5. ANDEXXA $27,683 42 payments
  6. NEUROFORM EZ 3 $27,362 6 payments
  7. COMANECI 17 $25,970 41 payments
  8. TIGERTRIEVER 17 REVASCULARIZATION DEVICE $25,673 39 payments
  9. NEUROFORM ATLAS $25,484 23 payments
  10. EMBOGUARD $22,336 23 payments
  11. Other $414,051 764 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Stryker Corporation $11,700 6 payments
  2. Balt USA, LLC $6,640 2 payments

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

11

Median for Neurosurgery: 83

Drug cost

$5,429

Median for Neurosurgery: $872

Branded share of claims

100%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Brilinta Ticagrelor Brand 11 $5,429

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 43 billing codes

Paid by Medicare

$71,007

Medicare's payments for the services billed

Medicare patients

81

Average age 75

Services billed

292

54 women, 27 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 60%
Ischemic heart disease 57%
Arthritis 56%
Chronic kidney disease 40%
Depression 36%
Atrial fibrillation 33%
Heart failure 30%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1,119 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record